UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027285 |
|---|---|
| Receipt number | R000031267 |
| Scientific Title | Analyses of the skin molecules in the patient of atopic dermatitis. |
| Date of disclosure of the study information | 2017/05/23 |
| Last modified on | 2019/06/25 12:39:35 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analyses of the skin molecules in the patient of atopic dermatitis.
Acronym
Analyses of the skin molecules in the patient of atopic dermatitis.
Scientific Title
Analyses of the skin molecules in the patient of atopic dermatitis.
Scientific Title:Acronym
Analyses of the skin molecules in the patient of atopic dermatitis.
Region
| Japan |
Condition
Condition
Atopic dermatitis
Classification by specialty
| Dermatology | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of the skin molecules in the patients of atopic dermatitis.
Basic objectives2
Others
Basic objectives -Others
The observational study the relationship between skin molecules and status of atopic dermatitis.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The relationship between skin molecules and status of atopic dermatitis.
Key secondary outcomes
The relationship between skin molecules and questionnaires.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 59 | years-old | >= |
Gender
Male
Key inclusion criteria
1.Japanese male panelists who are 20-59 years old.
2.Panelists with atopic dermatitis more than mild condition.
3.Panelists who have normal weight (BMI: Between 18.5 and 25.0)
4.Panelists who agree to have their typical daily routines.
Key exclusion criteria
1.Panelists who use the steroid and immunosuppressant in face for more than 2 weeks during a month.
2.Panelists who used the antibiotics in the last 2 weeks.
3.Panelists who have the disease, such as diabetes, affecting on this study.
4.Panelists who use the drugs affecting on this study.
5.Panelists who have undergone
some beauty treatments on their faces.
6.Panelists participating in, or scheduled to participate in, another study during the study period.
7.Panelists who smoke.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshito Takahashi |
Organization
Kao Corporation
Division name
R&D -Core Technology- Biological Science Research
Zip code
Address
5-3-28, Kotobuki-machi, Odawara-shi, Kanagawa, 250-0002, JAPAN
TEL
0465-34-6116
takahashi.yoshito@kao.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Takayoshi Inoue |
Organization
Kao Corporation
Division name
R&D -Core Technology- Biological Science Research
Zip code
Address
2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL
0285-68-7498
Homepage URL
inoue.takayoshi@kao.co.jp
Sponsor or person
Institute
Kao Corporation
Institute
Department
Personal name
Funding Source
Organization
Kao Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
株式会社インフォワード（東京都）
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 05 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 05 | Month | 23 | Day |
Date of IRB
| 2017 | Year | 05 | Month | 23 | Day |
Anticipated trial start date
| 2017 | Year | 06 | Month | 01 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Panelists will be recruited by Inforward, inc.
Management information
Registered date
| 2017 | Year | 05 | Month | 09 | Day |
Last modified on
| 2019 | Year | 06 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031267
